Life Science: Great Promise & Rapid Growth

TOP VC-FUNDED COMPANIES (2018)

COMPANY

ROUND

MONEY RAISED LEAD INVESTORS

Tmunity

Series A

$135M

University of Pennsylvania Health System, Gilead Sciences, Be The Match

Braeburn

Mezzanine

$110M

Wellington Capital Management

Galera Therapeutics

Series C

$70M

Clarus Ventures

Carisma Therapeutics

Series A

$53M

AbbVie Ventures, HealthCap

Velicept Therapeutics

Series B

$16M

Samsara BioCapital

Vesper Medical

Series A

$15M

New Enterprise Associates, Quaker Partners Management

Exision BioTherapeutics

Seed Funding

$10M

ARTIS Ventures, Oakhouse Partners

Scout Bio

Series A

$9M

Frazier Healthcare Partners

Proscia

Series A

$8M

Flybridge Capital Partners

IO BioSciences

Seed Funding

$695K

BioAdvance

Isoma Diagnostics

Seed Funding

$50K

Ben Franklin Technology Partners

Source: PitchBook, Crunchbase

RENT VS. VACANCY COMPARISON $14 $15 $16 $17 $18 $19 $20 $21 $22 $23 $24 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 Asking Rent, $ PSF (NNN) Overall Vacancy Rate

SUBMARKET STATS

0% 1% 2% 3% 4% 5% 6% 7% 8% 9% 10%

AVG. ASKING RENT (NNN)

INVENTORY (SF)

VACANCY

University City

$36.72

7,088,957 3.0%

PA Suburbs

$19.67

6,579,366 2.3%

Navy Yard

$37.00

518,000 0.0%

NOTABLE LEASE TRANSACTIONS (2018)

TENANT

SF

LANDLORD

ADDRESS

SUBMARKET

LEASE TYPE

Spark Therapeutics Inc.

53,267 Brandywine Realty Trust

3001 Market St

University City

New Lease/ Expansion New Lease/ Expansion/ Build-to-suit

WuXi Advanced Therapies

95,000 Liberty Property Trust

400 Rouse Boulevard Navy Yard

Thomas Jefferson University

25,000 MRA Group

727 Norristown Rd

PA Suburbs

New Lease

NOTABLE SALE TRANSACTIONS (2017 - 2018)

ADDRESS

SUBMARKET SF

BUYER

SELLER

PRICE TENANTS

709 Swedeland Rd

PA Suburbs

1,097,952 MLP Ventures GlaxoSmithKline $52M GlaxoSmithKline

727 Norristown Rd

PA Suburbs

591,000 MRA Group Dow Chemical Company

$10M Redevelopment

3001 Market St

University City 282,709 Brandywine Realty Trust

Drexel University $35M

Redevelopment, Spark Therapeutics Inc. signed lease after acquisition as anchor tenant

25

Contributors: Casandra Dominguez, casandra.dominguez@cushwake.com ; Vincent Planque, vincent.planque@cushwake.com